January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Precision Biosciences
Precision BioSciences is a publicly-traded ($DTIL), clinical stage, advanced gene editing company developing in vivo therapies that incorporate our proprietary, therapeutic grade gene editing technology, ARCUS.